CIK 0001382101
- Non-accelerated filer
- Smaller reporting company
SUTRO BIOPHARMA, INC.
Sign in to watch- Ticker
- STRO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 452441988
- Phone
- +1 650-392-8412
- Business address
- 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Former names
- SUTRO BIOPHARMA INC, Fundamental Applied Biology Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-09 | Chung Jane Chief Commercial Officer | Shares withheld for taxes | −6,483 | $6.60 | $43K | 14,767 |
| 2022-08-09 | Chung Jane Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit (RSU) | −18,750 | 56,250 | ||
| 2022-07-12 | Vasquez Nicki Chief Port. Strat & Alnce Ofcr | Exercise or conversion | +3,250 | 15,243 | ||
| 2022-07-12 | Vasquez Nicki Chief Port. Strat & Alnce Ofcr | Shares withheld for taxes | −1,123 | $6.08 | $7K | 14,120 |
| 2022-07-12 | Vasquez Nicki Chief Port. Strat & Alnce Ofcr | Exercise or conversion · Restricted Stock Unit (RSU) | −3,250 | 9,750 | ||
| 2022-06-06 | Wigginton Jon Marc Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | Sharp Shalini Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | Petree Daniel H Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | PANEK JAMES P Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | MATSUI CONNIE Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | Dybbs Michael Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | Hunter Heidi Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | Lobacki Joseph M Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-06-06 | Freund John Gordon Director | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2022-04-14 | Hallam Trevor Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion | +3,750 | 81,567 | ||
| 2022-04-14 | Hallam Trevor Pres. Rsrch & Cf. Sctific Ofcr | Shares withheld for taxes | −1,296 | $7.26 | $9K | 80,271 |
| 2022-04-14 | Hallam Trevor Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion · Restricted Stock Unit (RSU) | −3,750 | 11,250 | ||
| 2022-03-14 | NEWELL WILLIAM J CEO | Purchase | +10,000 | $7.75 | $78K | 116,525 |
| 2022-03-05 | FITZPATRICK LINDA A Chief People & Comm. Officer | Exercise or conversion | +8,750 | 39,296 | ||
| 2022-03-05 | FITZPATRICK LINDA A Chief People & Comm. Officer | Shares withheld for taxes | −2,972 | $8.17 | $24K | 36,324 |
Page 20 of 27 · 535 trades